Table 6.
Marker6-b | Coeff ± SE6-c | Wald χ2 | pvalue6-d | Odds ratio6-e |
---|---|---|---|---|
D1Mit11 | 1.87 ± 0.45 | 17.0 | <0.0001 | 6.50 |
D1Mit17 | 1.42 ± 0.45 | 10.0 | 0.0015 | 4.16 |
D3Mit268 | 0.88 ± 0.34 | 6.85 | 0.0089 | 2.41 |
D5Mit398 | 1.18 ± 0.42 | 8.19 | 0.0042 | 3.25 |
D6Mit102 | 1.13 ± 0.33 | 12.0 | 0.0005 | 3.09 |
Regression was conducted with the dependent variable defined as the presence (n = 335) or absence (n = 176) of tonic-clonic seizure activity.
Markers with significant phenotype-predictive value (see Table 5 for markers entered into analysis). Marker data were recoded to reflect the best-fitting mode of inheritance. Results are expressed in terms of the seizure-susceptibility allele.
Mean regression coefficient (±SEM) for the marker.
Probability that the regression coefficient equals 0.00.
Odds of expressing a PTZ-induced tonic-clonic seizure when possessing the susceptibility genotype at the indicated marker locus.